Results 181 to 190 of about 200,878 (264)

Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast. [PDF]

Breast Cancer Res Treat
Kaur M, Quirarte A, Vertido A, Torosian T, Li TM, Mouabbi JA, Mukhtar RA.   +6 more
europepmc   +1 more source

Race-related subsequent breast events after ductal carcinoma in situ: A Surveillance, Epidemiology, and End Results-based analysis. [PDF]

Cancer
Koric A, Jiang S, Liu Y, Colditz GA.
europepmc   +1 more source

Diagnostic, Prognostic, and Predictive Tissue Biomarkers in Urothelial Carcinoma In Situ: A Narrative Review. [PDF]

Diagnostics (Basel)
Sanguedolce F, Cormio A, Zanelli M, Zizzo M, Palicelli A, Falagario UG, Milanese G, Galosi AB, Mazzucchelli R, Cormio L, Carrieri G.   +10 more
europepmc   +1 more source

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

International Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin, Venugopalareddy Mekala, Jianrong Li, Xiang Wang, Muhammad Aminu, Jia Wu, Jianjun Zhang, Robert Taylor Ripley, Christopher I. Amos, Chao Cheng   +9 more
wiley   +1 more source

Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC). [PDF]

Int J Cancer
Näsman T, Birgersson M, Marklund L, Näsman A.   +3 more
europepmc   +1 more source

Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2‐dependent manner

International Journal of Cancer, EarlyView.
What's New? Hypoxic regions and inflammatory Th17 cells in the tumor environment are both associated with poor prognosis in cervical cancer. However, synergistic mechanisms between hypoxia and Th17 cells remain elusive. This study demonstrated Th17–hypoxia‐driven mechanisms underlying cervical cancer progression.
Selina Gies, Maike Pohlers, Tanja Tänzer, Emmanuel Ampofo, Matthias W. Laschke, Moritz Schäfer, Yoo‐Jin Kim, Rainer Maria Bohle, Erich‐Franz Solomayer, Konrad Wagner, Martin Empting, Alexandra K. Kiemer, Barbara Walch‐Rückheim   +12 more
wiley   +1 more source

Urothelial carcinoma in situ of the entire urinary tract with invasion into seminal vesicle: A case report. [PDF]

Urol Case Rep
Hsu VW, Swarbrick N, Kulkarni H, Redfern A, Hawks C, Picardo A, McCombie SP, Hayne D.   +7 more
europepmc   +1 more source

Age‐specific breast cancer incidence by subtype, TNM stage and screening status in Sweden 2008–2019 estimated with multiple imputation

International Journal of Cancer, EarlyView.
What's New? Breast cancer incidence in women increases with age, but which subtypes contribute the most at different ages remains unclear. Incidence patterns of breast cancer subtypes are typically under‐reported in population‐based studies due to a high proportion of cases lacking subtype information.
Leo Gkekos, Katrín Ásta Gunnarsdóttir, Keith Humphreys, Irma Fredriksson, Anna L. V. Johansson   +4 more
wiley   +1 more source

Integration of eQTL and GEO Datasets to Identify Genes Associated with Breast Ductal Carcinoma In Situ. [PDF]

Curr Issues Mol Biol
Mo CQ, Xie RW, Li WW, Zhong MJ, Li YY, Lin JY, Zhang JS, Zheng SK, Lin W, Kong LJ, Xu SW, Chen XJ.   +11 more
europepmc   +1 more source

Health care policy trial of primary human papillomavirus–based cervical screening in Denmark: Comparison of three triage algorithms

International Journal of Cancer, EarlyView.
What's New? Primary human papillomavirus (HPV)–based screening has shown superiority to cytology‐based screening in reducing cervical cancer risk in clinical trials. However, the benefit must be balanced with potential overdiagnosis/overtreatment.
Jeppe Bennekou Schroll, Jesper Bonde, Elsebeth Lynge, Marianne Waldstrøm, Petra Hall Viborg, Anna Frandsen, Rikke Holst Andersen, Susanne Merete Nielsen, Bettina Kjær Kristensen, Doris Schledermann, Berit Andersen, on behalf ofthe National Danish Cervical Cancer Screening Steering Committee   +11 more
wiley   +1 more source